Novavax Inc. buy Jefferies Financial Group Inc.
Start price
16.10.24
/
50%
€9.40
Target price
16.10.25
€23.02
Performance (%)
-23.69%
End price
17.10.25
€7.17
Summary
This prediction ended on 17.10.25 with a price of €7.17. The price of Novavax Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.69%. Jefferies_Financial_ has a follow-up prediction for Novavax Inc. where he still thinks Novavax Inc. is a Buy. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novavax Inc. | 5.995% | 5.995% | 48.340% |
| iShares Core DAX® | 1.498% | -0.265% | 5.212% |
| iShares Nasdaq 100 | 1.854% | -0.066% | 37.788% |
| iShares Nikkei 225® | 0.411% | 4.084% | 60.701% |
| iShares S&P 500 | 1.479% | 0.783% | 26.350% |
Comments by Jefferies_Financial_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax, Inc. (NASDAQ: NVAX) had its price target lowered by analysts at Jefferies Financial Group Inc. from $31.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for NVAX provided by MarketBeat
In the thread Trading Novavax Inc.
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten

